Catalyst Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/12/2026 | 375 | 0.0% | 16,080 | 12/31/2025 |
| 2025 Q3 | 10/22/2025 | 299 | 0.0% | 15,153 | 9/30/2025 |
| 2025 Q2 | 8/6/2025 | 818 | 0.0% | 37,702 | 6/30/2025 |
| 2025 Q1 | 5/9/2025 | 1,008 | 0.0% | 41,575 | 3/31/2025 |
| 2024 Q4 | 2/10/2025 | 821 | 0.0% | 39,331 | 12/31/2024 |
| 2024 Q3 | 10/18/2024 | 335 | 0.0% | 16,876 | 9/30/2024 |
| 2024 Q2 | 7/31/2024 | 293 | 0.0% | 18,899 | 6/30/2024 |
| 2024 Q1 | 4/29/2024 | 312 | 0.0% | 19,583 | 3/31/2024 |
| 2023 Q4 | 2/6/2024 | 340 | 0.0% | 20,221 | 12/31/2023 |
| 2023 Q3 | 10/23/2023 | 201 | 0.0% | 17,180 | 9/30/2023 |
| 2023 Q2 | 8/10/2023 | 323 | 0.0% | 24,004 | 6/30/2023 |
| 2023 Q1 | 5/11/2023 | 342 | 0.0% | 20,644 | 3/31/2023 |
| 2022 Q4 | 2/7/2023 | 376 | 0.0% | 20,236 | 12/31/2022 |
| 2022 Q3 | 11/14/2022 | 204 | 0.0% | 15,918 | 9/30/2022 |
| 2022 Q2 | 7/19/2022 | 95 | 0.0% | 13,685 | 6/30/2022 |
| 2022 Q1 | 5/4/2022 | 89 | 0.0% | 10,800 | 3/31/2022 |
| 2021 Q4 | 1/31/2022 | 87 | 0.0% | 12,855 | 12/31/2021 |
| 2021 Q3 | 10/29/2021 | 64 | 0.0% | 12,214 | 9/30/2021 |
| 2021 Q2 | 8/11/2021 | 63 | 0.0% | 11,056 | 6/30/2021 |
| 2021 Q1 | 5/4/2021 | 50 | 0.0% | 11,056 | 3/31/2021 |
| 2020 Q4 | 2/11/2021 | 41 | 0.0% | 12,315 | 12/31/2020 |
| 2020 Q3 | 11/5/2020 | 39 | 0.0% | 13,315 | 9/30/2020 |
| 2020 Q2 | 8/12/2020 | 61 | 0.0% | 13,315 | 6/30/2020 |
| 2020 Q1 | 5/11/2020 | 62 | 0.0% | 16,315 | 3/31/2020 |
| 2019 Q4 | 2/5/2020 | 61 | 0.0% | 16,315 | 12/31/2019 |